Autoimmune Myelofibrosis: A Case Review

Mell Gutarra-Arana, MD, and Tehniat Haider, MD, are rheumatology fellows at Indiana University School of Medicine in Indianapolis.
Theodore Kieffer, MD, is an anatomic and clinical pathology resident at Indiana University School of Medicine in Indianopolis.
Steven Hugenberg, MD, is chief of the Division of Rheumatology at Indiana University School of Medicine in Indianopolis.

References

1. Rizzi R, Pastore D, Liso A, et al. Autoimmune myelofibrosis: Report of three cases and review of the literature. Leuk Lymphoma. 2004 Mar;45(3):561–566.
2. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis. A steroid responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine (Baltimore). 1994;73(3):145–152.
3. Santos FP, Konoplev SN, Lu H, Verstovsek S. Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia. Leuk Res. 2010 Jan;34(1):e35–e37.
4. Mehta J, Wang H, Iqbal SU, Mesa R. Epidemiology of myeloproliferative neoplasms in the United States. Leuk Lymphoma. 2014 Mar;55(3):595–600.
5. Wanitpongpun C, Teawtrakul N, Mahakkanukrauh A, et al. Bone marrow abnormalities in systemic lupus erythematosus with peripheral cytopenia. Clin Exp Rheumatol. 2012 Nov–Dec;30(6):825–829.
6. Voulgarelis M, Giannouli S, Tasidou A, et al. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: A clinicopathological study. Am J Hematol. 2006 Aug;81(8):590–597.
7. Bass RD, Pullarkat V, Feinstein DI, et al. Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature. Am J Clin Pathol. 2001 Aug;116(2):211–216.
8. Hasselbalch H, Nielsen H, Berild D, Kappelgaard E. Circulating immune complexes in myelofibrosis. Scand J Haematol. 1985 Feb;34(2):177–180.
9. Kageyama Y. [A case of elderly-onset systemic lupus erythematosus (SLE) complicated with severe liver dysfunction and pancytopenia due to myelofibrosis.] (Article in Japanese.) Nihon Ronen Igakkai Zasshi. 1999 Dec;36(12):881–886.
10. Konstantopoulos K, Terpos E, Prinolakis H, et al. Systemic lupus erythematosus presenting as myelofibrosis. Haematologia (Budap). 1998;29(2):153–156.
11. Kaelin WG Jr, Spivak JL. Systemic lupus erythematosus and myelofibrosis. Am J Med. 1986 Nov;81(5):935–938.
12. Kiss E, Gál I, Simkovics E, et al. Myelofibrosis in systemic lupus erythematosus. Leuk Lymphoma. 2000 Nov;39(5–6):661–665.
13. Zandman-Goddard G, Levy Y, Shoenfeld Y. Intravenous immunoglobulin therapy and systemic lupus erythematosus. Clin Rev Allergy Immunol. 2005 Dec;29(3):219–228.
14. Harrison JS, Corcoran KE, Joshi D, et al. Peripheralmonocytes and CD4+ cells are potential sources for increased circulating levels of TGF-beta and substance P in autoimmune myelofibrosis. Am J Hematol. 2006 Jan;81(1):51–58.